Skip to content
WorldBrand.AI

Tecan

Corporate brand

UnclaimedRequest correction

A Swiss laboratory-automation and life-science technology company serving research, diagnostics, biopharmaceuticals and medical technology.

Last updated October 14, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Tecan is a Swiss life-science technology company whose core business is the automation of laboratory workflows. Founded in 1980 as Technische Analysegeräte, the company initially developed measuring, analytical and laboratory devices before concentrating increasingly on automated liquid handling and related instrumentation. Its systems are used by pharmaceutical and biotechnology companies, university and research laboratories, clinical diagnostic laboratories, forensic organizations and medical-technology manufacturers. The company operates through two closely connected business roles. Under its own brand, Tecan supplies laboratory automation platforms, liquid-handling systems, microplate readers, consumables and workflow solutions. It also acts as an original-equipment manufacturer, designing and producing instruments, components, pumps, modules and medical devices that partner companies incorporate into products sold under other brands. This OEM activity has broadened Tecan's exposure beyond the direct laboratory-instrument market and made the company a supplier to diagnostic and medical-device businesses. Tecan's product portfolio includes automated liquid-handling workstations, integrated workcells, sample-preparation systems, multimode microplate readers, automated laboratory logistics and specialized components. Products such as the Freedom EVO and Fluent platforms address flexible laboratory automation, while the Infinite family is associated with multimode microplate reading. The company also supplies technologies for genomics, proteomics, drug discovery, clinical testing, immunoassays, next-generation sequencing workflows and other analytical applications. Tecan's early development was marked by rapid internationalization and a period of financial difficulty. It established a North American presence in 1982, expanded into Asia in 1986 and acquired several businesses during the 1980s. After financial problems led to a major restructuring around 1989–1990, the company sold many subsidiaries and refocused on laboratory automation. It subsequently rebuilt through product development, international sales and selective acquisitions. Significant product and corporate milestones include the Genesis automation series in 1995, the Freedom EVO platform in 2003, and expansion through acquisitions between 2014 and 2021 into immunoassays, sample preparation, laboratory components, next-generation sequencing and medical-device manufacturing. Tecan is headquartered in Männedorf, with research and production activities in North America, Europe and the Asia-Pacific region, and a reported sales and service network covering 52 countries. The company is listed on the SIX Swiss Exchange under the ticker TECN.

History

Tecan was founded in Switzerland on March 18, 1980, by engineers Heinz Abplanalp, Heini Maurer, Heinz Möckli and Gallus Blater. The name originated from Technische Analysegeräte. Its first office was located in Abplanalp's home in Hombrechtikon, and early instruments were assembled in improvised premises that included renovated barns, apartments and warehouses. The founders aimed to develop measuring, analytical and laboratory-automation equipment. Tecan established Tecan US in Chapel Hill, North Carolina, in 1982 to support North American sales and marketing, together with a production operation for the US market. In 1984, the finance company Zelux acquired a substantial minority stake. Tecan entered automated pipetting in 1985 with the Sampler 500 series, described as a process-controlled automated pipetting platform. During the following years, the company expanded aggressively, opened Tecan Asia in Singapore and acquired businesses including Cavro Scientific Instruments, an OEM manufacturer of liquid-handling components, and SLT Laborinstrumente in Austria. This rapid expansion created a complex corporate structure and was followed by financial difficulties in 1989. Share trading was temporarily suspended, and in 1990, under CEO Hans Widmer, Tecan sold many subsidiaries and narrowed its focus. The continuing operations centered on liquid-handling robotics production in Switzerland, the United States and Austria, supported by selected sales centers. The consolidation restored profitability. Founder Heinz Abplanalp left in 1990, followed by the other founding members in 1991. Gottlieb Knoch became a major shareholder, board president and CEO in 1993. The company pursued operational standardization and product development during the 1990s. Its production sites obtained ISO 9001 certification in 1994, and the Genesis laboratory-automation series was launched in 1995. Perkin-Elmer acquired Knoch's shareholding in 1997, but later sold its Tecan shares on the open market. Tecan was restructured and returned to the main segment of the SWX Swiss Exchange in 1999. A marketing collaboration with Abbott Laboratories around the Genesis FE 500 Workcell followed in 1998. Tecan moved its headquarters to Männedorf in 2001. The company continued to build scale in laboratory automation, with more than 5,000 Genesis platforms reported sold within two years. The Freedom EVO platform was launched in 2003. In 2005, Tecan acquired REMP, a Swiss supplier of automated laboratory and logistics systems. Its product development also included the Infinite series of multimode microplate readers, which received innovation recognition in Austria in 2006. From 2014 onward, Tecan used acquisitions to broaden its capabilities and address adjacent parts of the life-science value chain. IBL International added immunoassay expertise; Sias expanded OEM laboratory automation; SPEware contributed sample-preparation solutions; Pulssar added piston pumps; and NuGEN brought next-generation sequencing kits and consumables. In 2021, the acquisition of Paramit extended Tecan's medical-device and life-science-instrument development and manufacturing platform. Today, Tecan combines branded laboratory automation with OEM engineering and manufacturing, serving customers across research, diagnostics, biopharmaceuticals, forensics and medical technology.

  • 2021

    Paramit is acquired

    [1]

    The transaction expands Tecan's OEM development and manufacturing presence in medical devices and life-science instruments.

  • 2014

    IBL International is acquired

    [1]

    Tecan expands into immunoassay technologies through the acquisition of IBL International.

  • 2003

    Freedom EVO launches

    [1]

    Tecan introduces the Freedom EVO laboratory-automation platform.

  • 2001

    Headquarters move to Männedorf

    [1]

    Tecan relocates its headquarters to Männedorf, Switzerland.

  • 1999

    Tecan returns to the SWX main sector

    [1]

    Following restructuring, Tecan is listed again in the main segment of the Swiss exchange.

  • 1995

    Genesis automation series launches

    [1]

    Tecan introduces the Genesis family of laboratory-automation workstations.

  • 1990

    Business is consolidated around laboratory automation

    [1]

    After financial difficulties, Tecan sells many subsidiaries and refocuses on liquid-handling robotics and related sales operations.

  • 1985

    Sampler 500 series enters the market

    [1]

    Tecan introduces process-controlled automated pipetting instruments.

  • 1982

    North American operations begin

    [1]

    Tecan opens a US sales and marketing organization and a production operation in North Carolina.

  • 1980

    Tecan is founded in Switzerland

    [1]

    Heinz Abplanalp, Heini Maurer, Heinz Möckli and Gallus Blater establish Technische Analysegeräte, the company that becomes Tecan.

Products and positioning

A high-end laboratory-automation and OEM technology supplier combining branded instruments, workflow solutions and embedded components for life-science and clinical applications.

  • Laboratory automation workstation · 2003

    Freedom EVO

    Launched in 2003, Freedom EVO is a modular automation platform for liquid handling and laboratory workflows. Its configurable architecture is intended to support applications such as sample preparation, genomics, proteomics, drug-discovery procedures and clinical laboratory processes. The platform represents one of Tecan's major branded automation families.

  • Laboratory automation workstation

    Fluent

    Fluent is Tecan's modern laboratory-automation platform for integrating liquid handling, laboratoryware management and workflow automation. It is positioned for research and diagnostic environments that need flexible, repeatable processing across multiple steps and instrument interfaces.

  • Multimode microplate reader

    Infinite series

    The Infinite series comprises multimode microplate readers used to measure several optical signals in biological and biochemical assays. The instruments support research workflows in areas including drug discovery, cellular analysis and molecular biology, and became associated with Tecan Austria's instrument-development activities.

  • Laboratory automation workstation · 1995

    Genesis

    Introduced in 1995, Genesis was a major Tecan laboratory-automation family based on updated electronics, communication protocols and storage concepts. It helped establish Tecan's position in automated liquid handling and was subsequently deployed in thousands of laboratories.

  • OEM liquid-handling components

    Cavro technologies

    Originating with the acquisition of Cavro Scientific Instruments, this technology family covers OEM liquid-handling components and systems used by partner companies in laboratory, diagnostic and analytical instruments. It reflects Tecan's role as an embedded-technology supplier as well as a branded-equipment maker.

Brand decisions

  • 2021

    Acquisition of ParamitM&A

    Background

    Tecan was broadening its OEM activities beyond laboratory instruments into medical devices and life-science manufacturing.

    Action taken

    Tecan acquired Paramit, a developer and manufacturer of medical devices and life-science instruments.

    Aftermath

    The transaction strengthened Tecan's contract-development and manufacturing capabilities.

    Source

  • 2003

    Launch of the Freedom EVO platformProduct launch

    Background

    Tecan sought to extend its laboratory-automation portfolio after the commercial development of the Genesis family.

    Action taken

    The company introduced Freedom EVO as a new automated laboratory-workstation platform.

    Aftermath

    Freedom EVO became one of Tecan's principal branded automation platforms.

    Source

  • 1990

    Concentration on laboratory automationStrategy

    Background

    Tecan faced financial difficulties after rapid expansion and a large number of subsidiaries had been assembled during the 1980s.

    Action taken

    Management sold a substantial portion of the subsidiary portfolio and retained core liquid-handling robotics operations and selected sales centers.

    Aftermath

    The refocused company returned to profitability and continued developing laboratory-automation platforms.

    Source

Recent events

  • 2021

    Tecan acquires Paramit[1]

    M&A

    The acquisition of Paramit strengthened Tecan's OEM development and manufacturing capabilities for medical devices and life-science instruments.

  • 2018

    Tecan acquires NuGEN Technologies[1]

    M&A

    Tecan expanded into next-generation sequencing kits and consumables through the acquisition of NuGEN Technologies.

  • 2017

    Tecan acquires Pulssar Technologies[1]

    M&A

    The acquisition added high-performance piston-pump technology used in in-vitro diagnostics and scientific-analysis instruments.

  • 2016

    Tecan acquires SPEware[1]

    M&A

    Tecan acquired SPEware, whose sample-preparation chemistry and automation technologies complemented Tecan's laboratory workflow business.

  • 2015

    Tecan acquires Sias[1]

    M&A

    The acquisition of Sias added an OEM supplier of laboratory-automation solutions to Tecan's portfolio.

  • 2014

    Tecan acquires IBL International[1]

    M&A

    Tecan acquired IBL International, an immunoassay company, expanding its presence in diagnostic assay technologies.

Sources7 sources

  1. 1Tecanen.wikipedia.org
  2. 2Tecan corporate websitetecan.com
  3. 3刚刚，Anthropic发布物理MCP：Claude开始接管真实世界finance.sina.com.cn
  4. 4Anthropic launches framework for AI agents to operate devicesbignewsnetwork.com
  5. 5Anthropic launches Model Hardware Standard for AI agentsthehindubusinessline.com
  6. 6Tecan acquires Paramit Corporationselectscience.net
  7. 7Tecan Group AG: Tecan successfully completes the acquisition of Paramitfinanznachrichten.de

Cite this profile: Cite the canonical profile. /brand-wiki/tecan · Editorial policy · How profiles are compiled